Abiopharma

Clinical trial NCT05461170 updates: 1. completion date: 2029-08-01 → 2032-05-01 2. primary completion date: 2029-08-01 → 2031-11-01

Clinical trial NCT06817356 updates: 1. primary completion date: 2026-08-01 → 2026-03-19 2. enrollment: 300 → 308 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05743881 updates: 1. completion date: 2026-09-30 → 2029-08-31 2. primary completion date: 2026-08-31 → 2029-08-31

Clinical trial NCT07425054 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-19

Clinical trial NCT06052631: start date: 2026-06-30 → 2026-07-01.

Clinical trial NCT07615010: start date: 2026-05-22 → 2026-05-26.

Mobix Labs Cancels Potential Share Issuance — Approximately 900,000 Shares Being Deregistered

Visa redéfinit son rôle dans le secteur du voyage avec le lancement mondial de Visa Destinations

SES AI Deadline Today: Rosen Law Firm Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES

General Announcement: Tax Ruling in respect of the S$300,000,000 3.25% Fixed Rate Perpetual Securities